Insulin news

All news on Insulin: plants, production capacities, investments and involved companies.

23 April 2026

Novo Nordisk: Oral semaglutide lowers HbA1c in adolescents with type 2 diabetes

PIONEER TEENS phase 3a: first oral GLP‑1 RA trial in 10–17‑year-olds with type 2 diabetes (n=132). 52‑week, placebo‑controlled; safety matched adult trials; regulatory filings planned H2.
5 March 2026

Roche Reports Positive Phase II Results for Petrelintide in Obesity Treatment

Petrelintide shows significant weight loss and good tolerability in Phase II trial, supporting further development for chronic weight management.
12 November 2015

Sanofi Expands in Höchst

Investing €200M, the company will build a fully automated cold warehouse and a multi-purpose building for medical tech, creating 500 jobs and expanding insulin production capabilities.
1 February 2011

Sanofi Opens Cell Culture Plant in Höchst

The new plant, costing EUR 30 million, will produce monoclonal antibodies for trials, doubling production capacity and enhancing the company's biopharmaceutical focus and market position.

Who will be producing Insulin in the future?

Find out with chemXplore Alpha

Learn more